mycoworks.com的 10 大竞争对手

ecovative.com

Ecovative, the world's premier mycelium technology company, today announced it has secured over $11 million in its latest funding round to fuel the explosive growth of My®Bacon, the flagship produ ...

grown.bio

Welcome to the world of exclusive luxury packaging, where every detail matters. Designed to protect & upgrade products.

boltthreads.com

B-silk™ and xl-silk™ are biotech-based silk polypeptides for skincare & beauty. Made with biotechnology, they are vegan, sustainable, & cruelty-free.

ptcbio.com

For Sam, publishing his first book was nerve-wracking – it chronicled his Friedreich’s ataxia (FA) diagnosis and was therefore very personal. He wasn’t sure what people would think, but he was pleased with the positive reception of his book. Sam is a passionate writer and has since published five more books. In this video, Sam…

ataibeckley.com

Explore the therapeutic areas where AtaiBeckley focuses its mental health innovation to address unmet patient needs.

hopkinspsychedelic.org

The Johns Hopkins Psychedelic Research Unit website provides information about or lab, current projects, future directions, and past achievements. Viewers can find media articles and academic publications pertaining to psychedelic research, psilocybin research, psilocybin studies, salvia research, f

zealandpharma.com

Zealand Pharma is a biotechnology company dedicated to developing innovative peptide-based medicines for people living with unmet medical needs

hansabiopharma.com

We develop lifesaving and life-altering treatments that can empower patients affected by rare immunologic conditions to live longer and healthier lives.

leibniz-fmp.de

Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, the Faculty of Medicine at Kiel University, and the Leibniz Institute of Virology in Hamburg are jointly receiving funding of nearly one million euros as part of the "Leibniz Cooperative Excellence" program. The goal of the project is to unravel fundamental mechanisms of two-pore domain potassium channels (K2P channels) – with potential new therapeutic approaches for cancer, autoimmune diseases, infectious diseases, central nervous system disorders, and cardiovascular diseases.